Home
AnHeart Therapeutics, Inc.

AnHeart Therapeutics, Inc. Market Share Analysis for July 2026

anheart therapeutics is a clinical stage global biopharmaceutical company developing a pipeline of novel precision oncology therapeutics for areas of significant unmet medical need.

Industry: N/A

Domainanhearttherapeutics.com

Year Founded2018

Employees51 - 200

Annual Revenue$2M - $5M

AnHeart Therapeutics, Inc.

AnHeart Therapeutics, Inc. (including company regionals)

anhearttherapeutics.com

See more website traffic and engagement information

AnHeart Therapeutics, Inc. Revenue up to July 2026 is 2M - 5M

revenue generated by AnHeart Therapeutics, Inc. top domains

AnHeart Therapeutics, Inc. top domains revenue over 3 years

Revenue for AnHeart Therapeutics, Inc. top domains

anhearttherapeutics.com2M - 5M

See more with Sales Intelligence

Total visits to AnHeart Therapeutics, Inc.'s top domains

Understand AnHeart Therapeutics, Inc. market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in AnHeart Therapeutics, Inc.'s top domains

Analyze AnHeart Therapeutics, Inc. engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on AnHeart Therapeutics, Inc.'s top domains

See how AnHeart Therapeutics, Inc. keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

AnHeart Therapeutics, Inc. top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by AnHeart Therapeutics, Inc.

These are the website technologies, by industry, used by AnHeart Therapeutics, Inc. top domains

Content Management System (2)

WordPress

Conversion & Analytics (2)

Google Analytics

Mobile (2)

Meta Viewport

Widget (2)

Twemoji

More Technologies

6

See all

News & Signals from AnHeart Therapeutics, Inc.

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsNuvation Bio, Inc. acquired AnHeart Therapeutics, Inc. for $397M on Apr 1st '24.Midtown East-based cancer treatment company AnHeart Therapeutics was acquired by San Francisco oncology company Nuvation Bio for $397 million in April of 2024, according to PitchBook.

NewsAnHeart Therapeutics, Inc. hired Amy Muse as Vice President, U.S. Commercial on Nov 9th '23.NEW YORK, November 09, 2023 --( BUSINESS WIRE )-- AnHeart Therapeutics ("AnHeart"), a global clinical-stage biopharmaceutical company developing novel precision therapies for people with cancer, today announced the appointments of Guilin Huang as Senior Vice President, Development and Amy Muse as Vice President, U.S. Commercial.